Science
At Alphabiome.ai, we are committed to revolutionize drug efficacy and patient outcomes by leveraging AI to transform microbiome data into actionable insights.
The Secrets of the Microbiome
The microbiome is often referred to as our second brain. Find out how the treasure chest of information stored there can revolutionize our approach to health and medicine.
Alphabiome’s Unique Approach
Alphabiome’s AI-driven proprietary technology deciphers trillions of genetic data fragments to identify biomarkers that will transform drug development by optimizing personalized treatment selection.
With over 100,000 biomarkers discovered, we are unlocking unprecedented opportunities for medical breakthroughs.
Leveraging vast genetic datasets, we empower pharmaceutical companies to predict treatment efficacy with greater accuracy – accelerating personalized medicine and improving patient outcomes.
Our technology seamlessly adapts across a broad spectrum of drugs and treatments, from blockbuster therapies to repurposed phase 2 candidates – driving diverse revenue streams through licensing, accelerated approvals, and targeted innovation.
With over 100,000 biomarkers discovered, we are unlocking unprecedented opportunities for medical breakthroughs.
Leveraging vast genetic datasets, we empower pharmaceutical companies to predict treatment efficacy with greater accuracy – accelerating personalized medicine and improving patient outcomes.
Our technology seamlessly adapts across a broad spectrum of drugs and treatments, from blockbuster therapies to repurposed phase 2 candidates – driving diverse revenue streams through licensing, accelerated approvals, and targeted innovation.
21/11/2025
New peer-reviewed publication: Alphabiome.ai AI Model Proven in Large-Scale Dairy Study
Our AI model, predicting the efficacy of an allicin-based essential oil for methane reduction, was peer-reviewed in Frontiers. The study validated our approach in 339 dairy cows on ten commercial farms.
17/09/2025
Validation of Alphabiome’s AI model for predicting microbiome driven outcomes
A peer-reviewed study confirms the accuracy of Alphabiome’s AI model, validated in a controlled livestock trial assessing the methane-reducing effect of a nutritional additive.
24/09/2025
Alphabiome’s AI model validated in large-scale multi-farm trial
In a study across 13 dairy farms, Alphabiome’s AI model accurately predicted the methane-reducing effect of an essential oil additive, demonstrating consistent performance under real-world conditions.
30/05/2025
Alphabiome Unveils Revolutionary AI Technology for Microbiome Decoding
Yahoo Finance- Using proprietary algorithms and advanced modeling, Alphabiome deciphers hidden microbial DNA to accurately predict individual drug response — setting a new standard in personalized medicine.
06/05/2025
AI That Predicts Drug Response Powered by the Microbiome
Health Technolog Net- Alphabiome’s proprietary platform analyzes microbial DNA beyond reference genomes, delivering unmatched accuracy in forecasting therapeutic outcomes.
22/01/2025
Alphabiome Raises $8M to Scale Microbiome AI
Finsmes.com- Alphabiome secures seed funding to expand R&D and advance its proprietary platform for predicting drug response with greater precision.
